The Latest Breaking News from Horizon

Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, for about $26.4 billion

"The acquisition of Horizon is a compelling opportunity for Amgen and the potential new medicines in Horizon's pipeline strongly complement our own R&D portfolio," said Amgen CEO Robert Bradway.

Stock futures edge higher into end-of-year push; Week Ahead: Fed Meeting highlights crucial series of central bank decisions; Boeing shares rise on report of Air India 737 Max deal; Microsoft takes 4% stake in London Stock Exchange Group and Horizon Therapeutics surges on report of $26 billion Amgen takeover.

Making a statement on the GLO (group litigation order) compensation scheme, Grant Shapps set out further details in the Commons for MPs.

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

"It is going to allow the volunteer-based clubs and some resort clubs, who shut their pro-shop early, to have unlimited access for players."

Horizon is considering potential offers from three Big Pharma stalwarts, sending HZNP stock soaring more than 25% early Wednesday.

Graham Hancock’s new Netflix documentary, about an advanced ancient civilisation that was wiped off the face of the Earth, has been accused by scientists and reviewers of espousing a ‘dangerous’ conspiracy theory. The value of the UK’s independently regulated broadcasters has never seemed clearer in comparison, writes Louis Chilton

Hydrogen made from renewable energy will be used to help power an Australian town for the first time as part of a landmark trial along the country's sun-drenched WA coast.

Scottish Criminal Cases Review commission rules six are entitled to appeal

SIX sub-postmasters caught up in the Horizon computer system scandal may have been victims of miscarriages of justice, the Scottish Criminal Cases…